Your session is about to expire
Atm Gene Mutation: What You Need To Know
Causes of A-T
A-T, or Ataxia-telangiectasia, is a genetic disorder. It's not caused by lifestyle choices or environmental factors. Instead, it comes from mutations in the ATM gene. This gene makes a protein that controls cell growth and division.
How do these mutations happen? They're inherited from parents. If both parents pass on a faulty ATM gene, A-T occurs. Both genes must be affected for the disease to develop.
The mutated ATM gene isn't capable of producing enough of its protein to control cell growth effectively. As a result, cells divide uncontrollably leading to medical issues characteristic of A-T such as movement problems and weakened immune systems.
Remember that everyone carries two copies of each gene - one from each parent. In cases where only one parent passes down the faulty ATM gene, this doesn't lead to A-T but causes the child to be an "ATM carrier." These carriers don't show symptoms themselves but can pass on the mutation to their children.
Inheritance Pattern of A-T
Ataxia-telangiectasia (A-T) is a rare genetic disorder. Its inheritance pattern? Autosomal recessive. What does this mean? It means that for a person to have A-T, they must inherit two copies of the abnormal gene - one from each parent.
Parents who carry one copy of the mutated gene are called carriers. They do not show signs or symptoms of A-T. However, when two carriers have a child together, there's a 25% chance their offspring will inherit both abnormal genes and develop A-T.
Each sibling also has another 50% chance of becoming an unaffected carrier like their parents while the remaining 25% chance could result in them inheriting no defective gene at all! This statistical probability applies to every pregnancy regardless of previous outcomes.
Remember: just because you or your partner are carriers doesn't mean your child will definitely get A-T. But it's important to understand these odds if you're planning on having children.
Preimplantation Genetic Diagnosis
Preimplantation Genetic Diagnosis (PGD) is a test. This test happens before pregnancy. It checks embryos for genetic conditions. Doctors use it mainly with in-vitro fertilization (IVF).
How does it work? Embryos are created in a lab, using IVF. A few cells are taken from each embryo when they're five days old. The cells are tested for specific genetic disorders.
Why use PGD? It helps identify genetic defects before pregnancy begins. This can provide valuable information to prospective parents, particularly those known to carry inheritable diseases.
PGD has its pros and cons. On the positive side, it reduces the chance of having a child with a serious health condition. However, there's no guarantee that an embryo identified as 'healthy' will result in a successful pregnancy or completely healthy baby.
Remember: PGD is a complex and expensive process. It also raises ethical questions about selecting embryos based on genetics.
Find Top Mutations Clinical Trials
Choose from over 30,000 active clinical trials.
Cancer Risks in A-T
Ataxia-telangiectasia (A-T) is a rare genetic disorder. It raises cancer risks significantly. This happens due to a mutation in the ATM gene. The ATM gene helps control cell division.
People with A-T have higher chances of developing leukemia and lymphoma. These are types of blood cancers. Other forms of cancer, such as breast or ovarian, can also occur.
Cancer risk varies among people with A-T. Some may develop cancer in childhood while others may not experience it until adulthood or even never at all.
Regular screenings are crucial for early detection and treatment. If you have A-T, talk to your doctor about an appropriate screening schedule.
Remember: knowledge empowers you in managing your health conditions!
Risks for A-T Carriers
A-T stands for Ataxia-Telangiectasia. It's a rare, inherited disorder. A-T carriers have an altered ATM gene but don't show symptoms of the disease. Yet, they face certain risks.
Cancer Risk: Carriers are more prone to cancer than non-carriers. Specifically, breast and pancreatic cancers pose greater threats.
Radiation Sensitivity: A-T carriers can respond abnormally to radiation. This includes medical radiation like X-rays and CT scans.
The knowledge about these risks is important in making health decisions. For example, choosing MRI over a CT scan to avoid unnecessary exposure to radiation.
Remember: genetic counseling is beneficial for understanding individual risks better.
Screening Options for A-T
Ataxia-telangiectasia (A-T) is a rare genetic disease. Early detection plays a key role in managing this condition.
Genetic testing is the primary screening option for A-T. It identifies mutations in the ATM gene, responsible for A-T. Doctors often recommend it if there's a family history of A-T or related symptoms.
Another method is Immunological testing. This checks levels of certain proteins and immune cells that are typically abnormal in individuals with A-T.
Regular neurological assessments can also be part of your screening strategy. They detect changes in movement coordination, muscle tone, and reflexes commonly seen with progressive neurological conditions like A-T.
Screening options don't provide a cure but they aid early diagnosis and treatment planning which can improve quality of life substantially.
Resources and More Information
Resources and More Information
To delve deeper into the world of clinical trials, a variety of resources exist. ClinicalTrials.gov is an excellent starting point. It's a database of private and public clinical studies around the globe.
Healthcare providers also serve as vital sources of information. They can provide guidance on suitable trials based on your medical history and current health status. You can discuss potential risks and benefits with them.
Books like "The Patient’s Guide to Clinical Trials" by J.Kerlavage offer insights too. This guide simplifies complex terms related to clinical trials, making it easier for you to understand.
For more personalized advice, consider joining patient communities or support groups online. Websites such as Smart Patients, PatientsLikeMe, and many others connect patients undergoing similar experiences across different conditions.
Remember, research is key when considering participation in a clinical trial. Explore these resources thoroughly before making any decisions.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Seshachalam, A., Cyriac, S., Reddy, N., & Gnana, S. (2010). Ataxia telangiectasia: Family management. Indian Journal of Human Genetics. CLOCKSS Archive.http://doi.org/10.4103/0971-6866.64940
- Basille, C., Frydman, R., Aly, A. E., Hesters, L., Fanchin, R., Tachdjian, G., … Achour-Frydman, N. (2009, July). Preimplantation genetic diagnosis: State of the art. European Journal of Obstetrics & Gynecology and Reproductive Biology. Elsevier BV.http://doi.org/10.1016/j.ejogrb.2009.04.004
- Hecht, F., & Hecht, B. K. (1990, May). Cancer in Ataxia-telangiectasia patients. Cancer Genetics and Cytogenetics. Elsevier BV.http://doi.org/10.1016/0165-4608(90)90003-s
- Schoenaker, M. H. D., Blom, M., de Vries, M. C., Weemaes, C. M. R., van der Burg, M., & Willemsen, M. A. A. P. (2019, November 11). Early diagnosis of ataxia telangiectasia in the neonatal phase: a parents’ perspective. European Journal of Pediatrics. Springer Science and Business Media LLC.http://doi.org/10.1007/s00431-019-03479-5